Anti-HER2 vaccines: new prospects for breast cancer therapy
/in Breast Cancer, Dendritic Cells, International Publications /von 2010-06-08 / Cancer Immunol. Immunother. 2010 Sep;59(9):1295-312Dendritic cell vaccination as a treatment modality for mesothelioma
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2010-06-01 / Expert Rev Respir Med 2010 Jun;4(3):311-4Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer
/in Gastric Cancer, International Publications, Newcastle Disease Virus /von 2010-06-01 / J. Mol. Med. 2010 Jun;88(6):589-96Immunotherapy of hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2010-06-01 / Expert Rev Gastroenterol Hepatol 2010 Jun;4(3):345-53INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect
/in Dendritic Cells, International Publications, SCLC /von 2010-06-01 / Expert Opin Biol Ther 2010 Jun;10(6):983-91
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution